Cerebra Integrated Technologies Limited

2 matters before the Securities Appellate Tribunal

Penalties and directions recorded

Allowed Rs 50 Crores loan infusion before equity after ECB regulatory approvals
Penalty to be paid within six weeks; separate appeals of Noticees 2-5 unaffected

SAT-appeal

SAT matter SATV-4F40F36ED56180E1096BAB1A
Call / listed on May 08, 2026 after mentioning
Appeal: Appeal (L) No. 147 of 2026 mentioned on 05.05.2026, next date May 08, 2026
Syphoning of company funds whilst Ranganathan Venkatraman was Director, leading to market access ban and penalty; company accepted findings.
Findings qua appellant upheld; para 22 directions upheld except limited market access for preferential allotment to Dr Sailesh Hiranandani and SRAM & MRAM group · Obtain affidavit from Dr Shailesh Hiranandani, Chairman SRAM & MRAM Group UK that he/group is unrelated to previous management
Appeal: Appeal No. 204 of 2025 disposed of on 06 October 2025 with findings upheld and limited infusion relief; Appeals No. 180, 179, 160, 161 by Noticees 2-5 to be decided separately

Analyse these matters in Ontology · Plans

Source: SecMarx — Cerebra Integrated Technologies Limited. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (charges, outcomes, appeal chain) is cited to us.